Showing results (181-190 of 287) with videos related to

Sort By:
Pageof 29
Journal of General Internal Medicine|March 18, 2023
A Randomized Clinical Trial of Clinician-Supported PTSD Coach in VA Primary Care PatientsKyle Possemato, Emily Johnson, Kimberly Barrie, et al.
Kidney International Reports|August 11, 2020
Functional Assessment of Fatigue and Other Patient-Reported Outcomes in Patients Enrolled in the Global aHUS RegistryLarry A Greenbaum, Christoph Licht, Vasileios Nikolaou, et al.
Science Immunology|February 25, 2022
Single-cell eQTL analysis of activated T cell subsets reveals activation and cell type-dependent effects of disease-risk variantsBenjamin J Schmiedel, Cristian Gonzalez-Colin, Vicente Fajardo, et al.
Clinical Kidney Journal|April 8, 2026
Ten tips on how to optimize nutrition in children with chronic kidney disease or on dialysisNonnie Polderman, Vanessa Shaw, Caroline E Anderson, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 28, 2014
Medication adherence and growth in children with CKDOleh M Akchurin, Michael F Schneider, Lucy Mulqueen, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 24, 2022
Vaccine Attitudes and COVID-19 Vaccine Intention Among Parents of Children With Kidney Disease or Primary HypertensionChia-Shi Wang, Rinchen Doma, Adrianna L Westbrook, et al.
Kidney International|June 17, 2018
Clinical and genetic predictors of atypical hemolytic uremic syndrome phenotype and outcomeFranz Schaefer, Gianluigi Ardissino, Gema Ariceta, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 13, 2012
T cell responses to known allergen proteins are differently polarized and account for a variable fraction of total response to allergen extractsCarla Oseroff, John Sidney, Randi Vita, et al.
The Journal of Pediatrics|June 21, 2014
Quality of life is improved and kidney function preserved in patients with nephropathic cystinosis treated for 2 years with delayed-release cysteamine bitartrateCraig B Langman, Larry A Greenbaum, Paul Grimm, et al.
JCI Insight|December 13, 2022
Tumor cells fail to present MHC-II-restricted epitopes derived from oncogenes to CD4+ T cellsSpencer E Brightman, Martin S Naradikian, Rukman R Thota, et al.
Pageof 29